Serum-Based DNA Methylation Biomarkers in Colorectal Cancer: Potential for Screening and Early Detection

Abstract excerpt

Colorectal cancer (CRC) is the third most common cause of cancer-related death in the United States. Early identification and treatment of pre-cancerous colorectal lesions, or node-negative CRC are highly effective interventions that substantially reduce disease-specific mortality. Colonoscopy remains a highly effective primary screening tool based on its excellent diagnostic accuracy, and its ability to remove...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Colorectal Cancer Screening and Detection
• Share to Epigenetics and DNA Methylation
• Share to Genetic factors in colorectal cancer